|
Market Closed -
OTC Markets
15:51:35 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.0225 USD | -2.17% |
|
-0.66% | -13.46% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAPY 0.0225 $
-2.17%
1.95K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAPY | 0.0225USD | -2.17% | 1.95K $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 2026-09-14 | 2026-09-15 | 2026-09-16 | 2026-09-17 | 2026-09-18 | |
|---|---|---|---|---|---|
| Last | US$0.0240 | US$0.0250 | US$0.0250 | US$0.0230 | US$0.0225 |
| Volume | 187,980 | 228,690 | 242,213 | 69,921 | 86,462 |
| Change | +5.96% | +4.17% | 0.00% | -8.00% | -2.17% |
| Opening | US$0.0202 | US$0.0180 | US$0.0201 | US$0.0250 | US$0.0100 |
| High | US$0.0245 | US$0.0268 | US$0.0259 | US$0.0250 | US$0.0230 |
| Low | US$0.0202 | US$0.0180 | US$0.0183 | US$0.0175 | US$0.0100 |
Performance
| 1 day | -2.17% | ||
| 1 week | -0.66% | ||
| 1 month | -16.67% | ||
| 3 months | -43.75% | ||
| 6 months | +25.00% | ||
| Current year | -13.46% | ||
| 1 year | -84.42% | ||
| 3 years | -96.91% | ||
| 5 years | -99.58% | ||
| 10 years | -99.68% |
Volumes
marketsDaily volume
86,462
Estimated daily volume
86,462
Avg. Volume 20 sessions
155,866
Daily volume ratio
0.55
Avg. Volume 20 sessions USD
3,506.99
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
5,963,660
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03%
Free-Float capitalization (USD)
5,018,493
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.0239
Moving average 20 days
0.0255
Moving average 50 days
0.0287
Moving average 100 days
0.0259
Price spread / (MMA5)
+6.22%
Price spread / (MMA20)
+13.33%
Price spread / (MMA50)
+27.56%
Price spread / (MMA100)
+15.11%
RSI 9 days
40.22
RSI 14 days
42.57
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.17% | -0.66% | -84.42% | -96.91% | 5.96M | |
| -0.58% | +0.43% | +32.58% | -6.20% | 78.35B | |
| -2.55% | +6.99% | +510.30% | +44.31% | 61.52B | |
| -1.11% | +5.08% | -11.48% | -33.39% | 59.78B | |
| +0.14% | -1.20% | -11.21% | +24.73% | 46.53B | |
| -0.24% | +1.22% | +2.36% | +154.40% | 45.5B | |
| -1.62% | -0.76% | +51.23% | -16.04% | 31.84B | |
| -1.81% | +3.16% | +44.82% | +106.78% | 25.4B | |
| +0.47% | +3.26% | +4.94% | +144.25% | 21.43B | |
| +0.27% | +1.96% | +59.19% | +106.18% | 15.77B | |
| Average | -0.92% | +1.91% | +59.83% | +42.81% | 38.61B | |
| Weighted average by Cap. | -0.92% | +2.35% | +94.93% | +39.85% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6b46879aa48b3efc6a75db6eaa0cc58.3k60NFVxFYuVTgpC5n2_N9tv4WL74kQ37C325ZcwGGg.7HjAfyASQMb_DW8bgz_Kcaoovgm0sCVvlHmkp6EAflDtONMDNkZ6yKN5Pg
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:51:35 | 0.0225 | 3,245 | 86,317 |
| 15:16:24 | 0.0225 | 2,000 | 83,072 |
| 15:11:52 | 0.0180 | 130 | 81,072 |
| 15:07:47 | 0.0180 | 4,000 | 80,942 |
| 15:05:23 | 0.0225 | 2,000 | 76,942 |
| 15:04:37 | 0.0225 | 3,000 | 74,942 |
| 15:04:01 | 0.0225 | 3,000 | 71,942 |
| 14:21:01 | 0.0180 | 159 | 68,942 |
| 13:58:49 | 0.0225 | 4,200 | 68,783 |
| 13:58:49 | 0.0225 | 1,800 | 64,583 |
Price Extremes
| 1 week | 0.01 |  | 0.03 |
| 1 month | 0 | | 0.03 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.28 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | -13.46% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
